Table of Contents Author Guidelines Submit a Manuscript
Cholesterol
Volume 2015, Article ID 147601, 3 pages
http://dx.doi.org/10.1155/2015/147601
Research Article

Nonselective Mevalonate Kinase Inhibitor as a Novel Class of Antibacterial Agents

1Department of Medicine, Islamic Azad University, Qom Branch, Qom 37157, Iran
2Department of Biochemistry, Payam Nour University of Mashhad, Mashhad 37157, Iran
3Department of Biochemistry, School of Medicine, Qom University of Medical Science, Qom 37157, Iran
4Booali Medical Research Center, Qom 37157, Iran

Received 30 September 2014; Revised 8 December 2014; Accepted 1 January 2015

Academic Editor: Shinichi Oikawa

Copyright © 2015 Mohammad Gharehbeglou et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. E. Oldfield, “Targeting isoprenoid biosynthesis for drug discovery: bench to bedside,” Accounts of Chemical Research, vol. 43, no. 9, pp. 1216–1226, 2010. View at Publisher · View at Google Scholar · View at Scopus
  2. V. Kuzina, C. Domenech, and E. Cerdá-Olmedo, “Relationships among the biosyntheses of ubiquinone, carotene, sterols, and triacylglycerols in Zygomycetes,” Archives of Microbiology, vol. 186, no. 6, pp. 485–493, 2006. View at Publisher · View at Google Scholar · View at Scopus
  3. P. A. Edwards and J. Ericsson, “Sterols and isoprenoids: signaling molecules derived from the cholesterol biosynthetic pathway,” Annual Review of Biochemistry, vol. 68, pp. 157–185, 1999. View at Publisher · View at Google Scholar · View at Scopus
  4. E. A. Johnson and W. A. Schroeder, “Microbial carotenoids,” Advances in Biochemical Engineering/Biotechnology, vol. 53, pp. 119–178, 1996. View at Google Scholar · View at Scopus
  5. A. Pelz, K.-P. Wieland, K. Putzbach, P. Hentschel, K. Albert, and F. Götz, “Structure and biosynthesis of staphyloxanthin from Staphylococcus aureus,” Journal of Biological Chemistry, vol. 280, no. 37, pp. 32493–32498, 2005. View at Publisher · View at Google Scholar · View at Scopus
  6. E. I. Wilding, J. R. Brown, A. P. Bryant et al., “Identification, evolution, and essentiality of the mevalonate pathway for isopentenyl diphosphate biosynthesis in gram-positive cocci,” Journal of Bacteriology, vol. 182, no. 15, pp. 4319–4327, 2000. View at Publisher · View at Google Scholar · View at Scopus
  7. W. N. Hunter, “The non-mevalonate pathway of isoprenoid precursor biosynthesis,” Journal of Biological Chemistry, vol. 282, no. 30, pp. 21573–21577, 2007. View at Publisher · View at Google Scholar · View at Scopus
  8. H. K. Lichtenthaler, “Non-mevalonate isoprenoid biosynthesis: enzymes, genes and inhibitors,” Biochemical Society Transactions, vol. 28, no. 6, pp. 785–789, 2000. View at Publisher · View at Google Scholar · View at Scopus
  9. J. Pérez-Gil and M. Rodríguez-Concepcíon, “Metabolic plasticity for isoprenoid biosynthesis in bacteria,” Biochemical Journal, vol. 452, no. 1, pp. 19–25, 2013. View at Publisher · View at Google Scholar · View at Scopus
  10. G. L. Curran and R. L. Costello, “Reduction of excess cholesterol in the rabbit aorta by inhibition of endogenous cholesterol synthesis,” The Journal of Experimental Medicine, vol. 103, no. 1, pp. 49–56, 1956. View at Publisher · View at Google Scholar
  11. M. Soveid, G. A. Dehghani, and G. R. Omrani, “Long-term efficacy and safety of vanadium in the treatment of type 1 diabetes,” Archives of Iranian Medicine, vol. 16, no. 7, pp. 408–411, 2013. View at Google Scholar · View at Scopus
  12. W. L. Holmes and N. W. Ditullio, “Inhibitors of cholesterol biosynthesis which act at or beyond the mevalonic acid stage,” The American Journal of Clinical Nutrition, vol. 10, pp. 310–322, 1962. View at Google Scholar · View at Scopus
  13. National Committee for Clinical Laboratory Standards, “Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically,” Approved Standards. NCCLS Document M7-A5, National Committee for Clinical Laboratory Standards, Wayne, Pa, USA, 2001. View at Google Scholar
  14. G. F. Gerberick and P. A. Castric, “In vitro susceptibility of Pseudomonas aeruginosa to carbenicillin, glycine, and ethylenediaminetetraacetic acid combinations,” Antimicrobial Agents and Chemotherapy, vol. 17, no. 4, pp. 732–735, 1980. View at Publisher · View at Google Scholar · View at Scopus
  15. A. S. Tracey, G. R. Willsky, and E. Takeuchi, Vanadium: Chemistry, Biochemistry, Pharmacology, and Practical Applications, CRC Press, Boca Raton, Fla, USA, 2007.